Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice A proposed model for drug screening
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 70 (1-2) , 107-114
- https://doi.org/10.1016/0021-9150(88)90104-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Lipid markers for atherosclerosisThe American Journal of Cardiology, 1986
- Rapid separation of plasma lipoproteins by gel permeation chromatography on agarose gel Superose 6BJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Primary prevention of coronary heart disease by lowering lipids: Results and implicationsAmerican Heart Journal, 1985
- Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.Journal of Lipid Research, 1985
- Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Effects of Gemfibrozil on Serum LipidsThe American Journal of Medicine, 1983
- Influence of nicotinic acid on metabolism of cholesterol and triglycerides in manJournal of Lipid Research, 1981
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955